Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer.
Scott DA, Aquila BM, Bebernitz GA, Cook DJ, Dakin LA, Deegan TL, Hattersley MM, Ioannidis S, Lyne PD, Omer CA, Ye M, Zheng X.
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4794-7. doi: 10.1016/j.bmcl.2008.07.093. Epub 2008 Jul 27.
Similar articles
Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.
Gopalsamy A, Lim K, Ellingboe JW, Mitsner B, Nikitenko A, Upeslacis J, Mansour TS, Olson MW, Bebernitz GA, Grinberg D, Feld B, Moy FJ, O'Connell J.
J Med Chem. 2004 Apr 8;47(8):1893-9.
Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods.
Khayat R, Batra R, Bebernitz GA, Olson MW, Tong L.
Biochemistry. 2004 Jan 20;43(2):316-22.
Rapid methods for screening low molecular mass compounds non-covalently bound to proteins using size exclusion and mass spectrometry applied to inhibitors of human cytomegalovirus protease.
Siegel MM, Tabei K, Bebernitz GA, Baum EZ.
J Mass Spectrom. 1998 Mar;33(3):264-73.
Development of a scintillation proximity assay for human cytomegalovirus protease using 33phosphorous.
Baum EZ, Johnston SH, Bebernitz GA, Gluzman Y.
Anal Biochem. 1996 May 15;237(1):129-34.
Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation.
Baum EZ, Ding WD, Siegel MM, Hulmes J, Bebernitz GA, Sridharan L, Tabei K, Krishnamurthy G, Carofiglio T, Groves JT, Bloom JD, DiGrandi M, Bradley M, Ellestad G, Seddon AP, Gluzman Y.
Biochemistry. 1996 May 7;35(18):5847-55.
Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.
Baum EZ, Siegel MM, Bebernitz GA, Hulmes JD, Sridharan L, Sun L, Tabei K, Johnston SH, Wildey MJ, Nygaard J, Jones TR, Gluzman Y.
Biochemistry. 1996 May 7;35(18):5838-46.
Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants.
Jones TR, Sun L, Bebernitz GA, Muzithras VP, Kim HJ, Johnston SH, Baum EZ.
J Virol. 1994 Jun;68(6):3742-52.
Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.
Baum EZ, Bebernitz GA, Hulmes JD, Muzithras VP, Jones TR, Gluzman Y.
J Virol. 1993 Jan;67(1):497-506.
Purification, properties, and mutagenesis of poliovirus 3C protease.
Baum EZ, Bebernitz GA, Palant O, Mueller T, Plotch SJ.
Virology. 1991 Nov;185(1):140-50.
beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.
Baum EZ, Bebernitz GA, Gluzman Y.
Proc Natl Acad Sci U S A. 1990 Dec;87(24):10023-7.
Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5573-7.
K-ras oncogene expression in Xenopus laevis.
Baum EZ, Bebernitz GA.
Oncogene. 1990 May;5(5):763-7.
Filters: Manage Filters